FDA notifies Amazon over sale of certain harmful sexual enhancement... > 자유게시판 | 그누보드5

FDA notifies Amazon over sale of certain harmful sexual enhancement... > 자유게시판

본문 바로가기
사이트 내 전체검색

자유게시판

FDA notifies Amazon over sale of certain harmful sexual enhancement...

페이지 정보

profile_image
작성자 Sibyl
댓글 0건 조회 60회 작성일 25-06-09 08:06

본문

July 29 (Reuters) - The U.S Food and Drug Administration (FDA) notified Amazon.com Inc over the sale of sexual enhancement and weight-loss products that had potentially harmful drug ingredients, in a letter addressed to the company's new boss Andy Jassy.

Amazon said it has removed the products in question, and 레비트라 강직도 will continue to work with the agency.

class=The FDA had already warned consumers in December website to avoid male enhancement and weight-loss products sold through Amazon, eBay and other retailers, 레비트라 인터넷 구매 citing hidden, dangerous drug ingredients.

In a letter website dated July 26, the FDA said it tested dozens of products it bought from December 2019 to February 2020 and found they contained one or more of the drug ingredients sildenafil, tadalafil and vardenafil.

None of these ingredients were named in the products' labeling, 레비트라 강직도 the health regulator said.

Sildenafil, tadalafil and vardenafil are active ingredients in FDA-approved prescription drugs Viagra, Cialis and Levitra, which are used to treat erectile dysfunction.

Those ingredients could interact with some prescription drugs and may lower blood pressure to dangerous levels, the FDA said.

"We continue to find potentially dangerous products available for purchase and urge stores, websites and online marketplaces, including Amazon, to do more to protect consumers by not selling or facilitating the sale of potentially dangerous and illegal FDA-regulated products," the health regulator said on Twitter on Thursday.

In one instance, the FDA said it had purchased a product from the Amazon website which the company had previously said it had restricted, adding it was concerned the e-commerce website's filters were inadequate.

The FDA has asked Amazon to submit a written response within 15 working days on steps it has taken to address such violations.

(Reporting by Nivedita Balu, Manas Mishra, and Tiyashi Datta in Bengaluru; Editing by Krishna Chandra Eluri)

댓글목록

등록된 댓글이 없습니다.

회원로그인

회원가입

사이트 정보

회사명 : 회사명 / 대표 : 대표자명
주소 : OO도 OO시 OO구 OO동 123-45
사업자 등록번호 : 123-45-67890
전화 : 02-123-4567 팩스 : 02-123-4568
통신판매업신고번호 : 제 OO구 - 123호
개인정보관리책임자 : 정보책임자명

공지사항

  • 게시물이 없습니다.

접속자집계

오늘
4,443
어제
6,284
최대
6,284
전체
312,208
Copyright © 소유하신 도메인. All rights reserved.